Gene · 6326
Papers4,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Telehealth for patients with rare epilepsies. | Ther Adv Rare Dis | 2022 | 37180417 | PubTator, text mining | PubMed |
| The voltage-sensing domain of a hERG1 mutant is a cation-selective channel. | Biophys J | 2022 | 36815709 | PubTator, text mining | PubMed |
| [Chinese guideline for diagnosis and treatment of transfusion dependent β-thalassemia (2022)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709178 | PubTator, text mining | PubMed |
| Modelling eNvironment for Isoforms (MoNvIso): A general platform to predict structural determinants of protein isoforms in genetic diseases. | Front Chem | 2022 | 36700074 | PubTator, text mining | PubMed |
| MAGI-MS: multiple seed-centric module discovery. | Bioinform Adv | 2022 | 36699383 | PubTator, text mining | PubMed |
| Identification of rare thalassemia variants using third-generation sequencing. | Front Genet | 2022 | 36685902 | PubTator, text mining | PubMed |
| The Sea Anemone Neurotoxins Modulating Sodium Channels: An Insight at Structure and Functional Activity after Four Decades of Investigation. | Toxins (Basel) | 2022 | 36668828 | PubTator, text mining | PubMed |
| Identifying the mechanisms and molecular targets of Hongjingtian injection on treatment of TGFβ1-induced HK-2 cells: coupling network pharmacology with experimental verification. | Ann Transl Med | 2022 | 36660701 | PubTator, text mining | PubMed |
| Therapeutic Potential of Active Components from Acorus gramineus and Acorus tatarinowii in Neurological Disorders and Their Application in Korean Medicine. | J Pharmacopuncture | 2022 | 36628348 | PubTator, text mining | PubMed |
| Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study. | Front Neurol | 2022 | 36619920 | PubTator, text mining | PubMed |
| Analysis of trio test in neurodevelopmental disorders. | Front Pediatr | 2022 | 36619507 | PubTator, text mining | PubMed |
| CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders. | Int J Mol Sci | 2022 | 36613684 | PubTator, text mining | PubMed |
| Cinacalcet inhibition of neuronal action potentials preferentially targets the fast inactivated state of voltage-gated sodium channels. | Front Physiol | 2022 | 36601343 | PubTator, text mining | PubMed |
| Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims. | Front Cell Dev Biol | 2022 | 36589745 | PubTator, text mining | PubMed |
| Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells. | J Nanobiotechnology | 2022 | 36585678 | PubTator, text mining | PubMed |
| The 'ForensOMICS' approach for postmortem interval estimation from human bone by integrating metabolomics, lipidomics, and proteomics. | Elife | 2022 | 36583441 | PubTator, text mining | PubMed |
| Diagnostic potential of the amniotic fluid cells transcriptome in deciphering mendelian disease: a proof-of-concept. | NPJ Genom Med | 2022 | 36577754 | PubTator, text mining | PubMed |
| Computational design of peptides to target NaV1.7 channel with high potency and selectivity for the treatment of pain. | Elife | 2022 | 36576241 | PubTator, text mining | PubMed |
| Clinical and genetic study of developmental and epileptic encephalopathy in Argentinean pediatric patients. | Medicina (B Aires) | 2022 | 36571524 | PubTator, text mining | PubMed |
| Blood Transfusion Vs. Hydroxyurea for Stroke Prevention in Children With Sickle Cell Anemia: A Systematic Review and Meta-Analysis. | Cureus | 2022 | 36569706 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6326/papers?page=31